DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,016,462 | +3.5% | 4,097 | +0.1% | 0.34% | +4.6% |
Q2 2023 | $982,080 | -5.9% | 4,092 | -1.2% | 0.33% | -9.9% |
Q1 2023 | $1,043,442 | -7.1% | 4,140 | -2.2% | 0.36% | -7.8% |
Q4 2022 | $1,122,944 | +5.2% | 4,231 | +2.4% | 0.40% | -6.8% |
Q3 2022 | $1,067,000 | +2.1% | 4,131 | +0.3% | 0.42% | +6.3% |
Q2 2022 | $1,045,000 | -12.6% | 4,120 | +1.2% | 0.40% | +1.0% |
Q1 2022 | $1,195,000 | -10.9% | 4,073 | -0.1% | 0.40% | -13.2% |
Q4 2021 | $1,341,000 | -1.3% | 4,076 | -2.7% | 0.46% | -7.9% |
Q3 2021 | $1,358,000 | +22.7% | 4,188 | -3.1% | 0.49% | +15.4% |
Q2 2021 | $1,107,000 | +15.0% | 4,323 | -1.4% | 0.43% | +1.4% |
Q1 2021 | $963,000 | -1.1% | 4,384 | 0.0% | 0.42% | -3.0% |
Q4 2020 | $974,000 | -17.2% | 4,384 | -19.8% | 0.44% | -24.6% |
Q3 2020 | $1,177,000 | +31.4% | 5,464 | +7.9% | 0.58% | +8.5% |
Q2 2020 | $896,000 | +30.8% | 5,064 | +2.3% | 0.53% | +9.0% |
Q1 2020 | $685,000 | -13.4% | 4,949 | -3.9% | 0.49% | +21.1% |
Q4 2019 | $791,000 | +7.9% | 5,149 | +1.4% | 0.40% | +3.9% |
Q3 2019 | $733,000 | -23.6% | 5,078 | -24.4% | 0.39% | +15.1% |
Q2 2019 | $959,000 | +30.8% | 6,714 | +20.9% | 0.34% | -19.2% |
Q1 2019 | $733,000 | +9.9% | 5,552 | -14.1% | 0.42% | -0.2% |
Q4 2018 | $667,000 | – | 6,467 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |